0001225208-18-000464.txt : 20180103 0001225208-18-000464.hdr.sgml : 20180103 20180103183131 ACCESSION NUMBER: 0001225208-18-000464 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171229 FILED AS OF DATE: 20180103 DATE AS OF CHANGE: 20180103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WHITE TONY L CENTRAL INDEX KEY: 0001171315 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 18507485 MAIL ADDRESS: STREET 1: C/O APPLERA CORP STREET 2: 301 MERRITT 7, PO BOX 5435 CITY: NORWALK STATE: CT ZIP: 06856-5435 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0306 4 2017-12-29 0000009892 BARD C R INC /NJ/ BCR 0001171315 WHITE TONY L C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Common Stock 2017-12-29 4 D 0 15523.1239 0 D 0.0000 D Option (Right to Buy) 88.7550 2017-12-29 4 D 0 1200.0000 0.0000 D 2018-07-09 Common Stock 1200.0000 0.0000 D Option (Right to Buy) 81.6950 2017-12-29 4 D 0 1200.0000 0.0000 D 2019-12-09 Common Stock 1200.0000 0.0000 D Phantom Stock Units 2017-12-29 4 D 0 20014.2200 D Common Stock 20014.2200 0.0000 D Share Equivalent Units 2017-12-29 4 D 0 25002.0000 D Common Stock 25002.0000 0.0000 D This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated. These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. Conversion is 1 for 1. These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement. Includes 10,934.90 units for dividend credits. Units granted under the Company's Stock Equivalent Plan for Outside Directors. These units, which are 100% vested, were assumed by BD at the effective time of the Merger. Myra McGinley, Attorney-in-Fact 2018-01-03